• "Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review"
• A case report of dipeptidyl peptidase 4 inhibitor-related kidney disease combined with renal cancer
• A genetic basis for sex differences in Xp11 translocation renal cell carcinoma
• A nomogram predicting intraoperative adverse events during minimally invasive radical nephrectomy and thrombectomy
• A prognostic model constructed by ferroptosis-associated genes (FAGs) in papillary renal cell carcinoma (PRCC) and its association with tumor mutation burden (TMB) and immune infiltration
• A prognostic signature based on genes associated with m6A/m5C/m1A/m7G modifications and its immunological characteristics in clear cell renal cell carcinoma
• AUY922 improves sensitivity to sunitinib in clear cell renal cell carcinoma based on network pharmacology and in vitro experiments
• Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab
• Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
• Bioinformatics analysis to disclose shared molecular mechanisms between type-2 diabetes and clear-cell renal-cell carcinoma, and therapeutic indications
• Cabozantinib as an emerging standard of care in renal cell carcinoma: clarifying the data?
• Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism
• Case report: response to immunotherapy and association with the fh gene in hereditary leiomyomatosis and renal cell cancer-associated renal cell cancer
• Changes in outcome of patients with advanced non-clear cell renal cell carcinoma from the tyrosine kinase inhibitor era to the immuno-oncology era
• Changes in the overall survival of patients with metastatic renal cell carcinoma in the era of immune-checkpoint inhibitors
• Chromophobe Renal Cell Carcinoma in a Pediatric Patient with Neurofibromatosis Type 1: A Case Report and Review of the Literature
• Clinical characteristics of renal cell carcinoma in the transplanted kidney in renal transplant recipients: a systematic scoping review
• Clinical outcomes and prognostic factors in metastatic nonclear cell renal cell carcinoma treated with immuno-oncology combination therapy
• Comparison of Trifecta and Pentafecta Outcomes across 3 Surgical Modalities of Partial Nephrectomy (PN) - Open, Lap, and Robotic
• Comprehensive Analysis Reveals Epithelial Growth Factor Receptor as a Potential Diagnostic Biomarker in Glioblastoma Multiforme
• Comprehensive multi-omics analysis reveals a combination of lncRNAs that synergistically regulate glycolysis and immunotherapeutic effects in renal clear cell carcinoma
• Construction of an autophagy-related genes risk model as predicting prognosis: BAG1 suppresses growth of clear cell renal cell carcinoma
• Cooperation between SIX1 and DHX9 transcriptionally regulates integrin-focal adhesion signaling mediated metastasis and sunitinib resistance in KIRC
• Cost trends of Metastatic Renal Cell Carcinoma Therapy: the impact of oral anticancer agents and immunotherapy
• Cutaneous leiomyosarcoma in a case of hereditary leiomyomatosis and renal cell carcinoma syndrome
• Deep learning-based diagnosis and survival prediction of patients with renal cell carcinoma from primary whole slide images
• Development and experimental validation of hypoxia-related gene signatures for osteosarcoma diagnosis and prognosis based on WGCNA and machine learning
• Diagnosis and open excision of concurrent pelvic schwannoma and chromophobe renal cell carcinoma
• Differential effect of asparagine and glutamine removal on three adenocarcinoma cell lines
• Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma
• DNA Origami-Constructed Nanotapes for Sunitinib Adsorption and Inhibition of Renal Clear Carcinoma Cells
• Effect of cruciferous vegetable intake on cancer: An umbrella review of meta-analysis
• Elucidating the pan-oncologic landscape of S100A9: prognostic and therapeutic corollaries from an integrative bioinformatics and Mendelian randomization analysis
• Endobronchial metastasis secondary to renal clear cell carcinoma: A case report
• Endolymphatic Sac Tumors Associated With von Hippel-Lindau: A Case Report Highlighting Opportunity for Novel Orphan Drug Therapy
• Epigenetic dysregulated long non-coding RNAs in renal cell carcinoma based on multi-omics data and their influence on target drugs sensibility
• Evaluating trophinin associated protein as a biomarker of prognosis and therapy response in renal cell carcinoma
• Exosomes in Renal Cell Cancer: Diagnostic and Therapeutic Nanovehicles
• First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study
• Focally Spared Region in Diffuse Type of Liver Metastasis From Renal Cell Carcinoma
• Frequency of benign tumors after partial nephrectomy and the association between malignant tumor findings and preoperative clinical parameters
• Fumarate hydratase-deficient renal cell carcinoma: A rare case report
• Hexokinase HK3-mediated O-GlcNAcylation of EP300: a key regulator of PD-L1 expression and immune evasion in ccRCC
• HNRNPD regulates the biogenesis of circRNAs and the ratio of mRNAs to circRNAs for a set of genes
• HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES
• Identification of a cancer driver gene-associated lncRNA signature for prognostic prediction and immune response evaluation in clear cell renal cell carcinoma
• Immune-related Adverse Event with Checkpoint Inhibitors Might Be an Emerging Underlying Disease of Steroid-related Osteonecrosis of the Femoral Head: A Case Report
• Immune-Related Adverse Events Can Predict Progression-Free and Overall Survival In Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors
• Impact of tumor multiplicity on the prognosis of patients with primary renal cell carcinoma: a SEER database analysis
• In-vivo and in-vitro toxicity evaluation of 2,3-dimethylquinoxaline: An antimicrobial found in a traditional herbal medicine
• Incidentally Detected Primary Squamous Cell Carcinoma of Kidney Arising from Renal Pelvis Impersonating Xanthogranulomatous Pyelonephritis
• Initial Stage of Gastric Metastasis From Renal Cell Carcinoma
• Innovative solutions? Belzutifan therapy for hemangioblastomas in Von Hippel-Lindau disease: A systematic review and single-arm meta-analysis
• Integrated Analysis of Clinical Outcome of Mesenchymal Stem Cell-related Genes in Pan-cancer
• ITGB3 is a Novel Prognostic Biomarker and Correlates with Aberrant Methylation and Tumor Immunity in Clear Cell Renal Cell Carcinoma
• KIR2DL2/DL3+NKs and Helios+Tregs in peripheral blood predict nivolumab response in patients with metastatic renal cell cancer
• Letter Re: High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma
• m⁶A modification of lncRNA in middle ear cholesteatoma
• MDH2 regulates the sensitivity of clear cell renal cell carcinoma to ferroptosis through its interaction with FSP1
• METTL3 and IGF2BP1-mediated m6A modification of ZHX2 promotes tumor property of renal cell carcinoma
• Mixed glandular neuroendocrine carcinoma of the endometrium with hypercalcemic crisis
• Molecular understanding and clinical aspects of tumor-associated macrophages in the immunotherapy of renal cell carcinoma
• Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer
• MZT2A serves as a prognostic biomarker and promotes the progression of kidney renal clear cell carcinoma
• Nc-RNA-mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma
• Neoadjuvant cabozantinib restores CD8 T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial
• New insight into the CNC-bZIP member, NFE2L3, in human diseases
• Optimal sequential therapy using tyrosine kinase inhibitors as the first-line treatment in patients with metastatic renal cell carcinoma: A nationwide multicenter study
• Predicting CTLA4 expression and prognosis in clear cell renal cell carcinoma using a pathomics signature of histopathological images and machine learning
• Predicting tumor mutation burden and VHL mutation from renal cancer pathology slides with self-supervised deep learning
• Preoperative Computed Tomography Imaging Accurately Identifies Adrenal Gland Involvement In Patients With Renal Masses
• Primary Ewing's Sarcoma of the Kidney Mimicking Renal Cell Carcinoma With Widespread Metastasis: A Case Report and a Brief Review of the Literature
• Prognostic impact and genomic backgrounds of renal parenchymal infiltration or micronodular spread in non-metastatic clear cell renal cell carcinoma
• Prognostic Model and Immune Response of Clear Cell Renal Cell Carcinoma Based on Co-Expression Genes Signature
• Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab
• Prognostic values of blood urea nitrogen/creatinine and cystatin C in patients with radical nephrectomy for renal cell carcinoma
• Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort
• Renal and Urinary Conditions: Kidney Cysts and Tumors
• Renal Cell Carcinoma Pancreatic Metastasis Protrusion From Duodenal Papilla
• Renal clear cell carcinoma undergoing cystic change: A cases report and review of the literature
• Results of Radical Nephrectomy and Inferior Vena Cava Thrombectomy
• Retroperitoneal schwannoma mimicking a metastatic lymph node of renal clear cell carcinoma: a case report
• Significance of Charlson co-morbidity index as predictive factor for post-op complications after radical nephrectomy
• Single-cell RNA-seq reveals heterogeneity in metastatic renal cell carcinoma and effect of anti-angiogenesis therapy in the pancreas metastatic lesion
• SOX11 as a prognostic biomarker linked to m6A modification and immune infiltration in renal clear cell carcinoma
• Sub-regional Radiomics Analysis for Predicting Metastasis Risk in Clear Cell Renal Cell Carcinoma: A Multicenter Retrospective Study
• Surveillance strategies for renal cell carcinoma in the renal allograft: balancing early detection and resource utilization
• Targeted gene sequencing reveals disparate genomic mutations between young and older adults in renal cell carcinoma
• Targeting multiple receptor tyrosine kinases with sitravatinib: A Phase 1b study in advanced renal cell carcinoma and castrate-resistant prostate cancer
• TFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinoma
• The Anti-Metastatic Action of Oxyresveratrol via Suppression of Phosphoryl-ERK/-PKCalpha-Mediated Sp1/MMP1 Signaling in Human Renal Carcinoma Cells
• The effect of enhanced recovery after surgery (ERAS) in renal surgery
• The efficacy and safety of cabozantinib in patients with metastatic or advanced renal cell carcinoma: a systematic review and meta-analysis
• The influence of sex hormones on renal cell carcinoma
• The potential of lenvatinib in breast cancer therapy
• The role of BUD31 in clear cell renal cell carcinoma: prognostic significance, alternative splicing, and tumor immune environment
• The Treatment of Metastatic Renal Cell Carcinoma
• Transcriptome- and proteome-wide association studies identify genes associated with renal cell carcinoma
• Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment
• Use of Radiation Therapy for Ataxia-Telangiectasia Mutated (ATM)-Mutation Metastatic Renal Cell Carcinoma: A Case Report